Home | GSK US
WO2019008441A1 - Compounds comprising cleavable linker and uses thereof - Google Patents
January 2023
GSK269962A (GSK 269962) | ROCK Inhibitor | MedChemExpress
Synthesis and Evaluation of Pseudomonas aeruginosa ATP Synthase Inhibitors | ACS Omega
Full article: Safety and efficacy results of simulated post-exposure prophylaxis with human immune globulin (HRIG; KEDRAB) co-administered with active vaccine in healthy subjects: a comparative phase 2/3 trial
US5530101A - Humanized immunoglobulins - Google Patents
ACCP Abstract Booklet - 2021 - Clinical Pharmacology in Drug Development - Wiley Online Library
WO2020092528A1 - Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity - Google Patents
GSK429286A | ROCK Inhibitor | MedChemExpress
Home | GSK US
Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A3 Receptor Expression | Journal of Medicinal Chemistry
Home | GSK US
Products A-Z | GSK
Home | GSK US
Glaxo Specialty 49702026423 - McKesson Medical-Surgical
Glaxo Smith Kline 58160082052 - McKesson Medical-Surgical
229625-50-7|Di-tert-butyl chloromethyl phosphate| Ambeed
![WO2014145715A1 - Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide - Google Patents](https://patentimages.storage.googleapis.com/25/02/44/0061230f9058d1/imgf000055_0002.png "WO2014145715A1 - Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide - Google Patents")
WO2014145715A1 - Metabolites of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide - Google Patents
Medrol dose pack good rx generic online USA
Industry Perspectives on Process Analytical Technology: Tools and Applications in API Development | Organic Process Research & Development
US5530101A - Humanized immunoglobulins - Google Patents
Glaxo Smith Kline 58160082652 - McKesson Medical-Surgical
Biomolecules | Free Full-Text | Post-Treatment of Synthetic Polyphenolic 1,3,4 Oxadiazole Compound A3, Attenuated Ischemic Stroke-Induced Neuroinflammation and Neurodegeneration
WO2018217651A1 - Kras g12c inhibitors and methods of using the same - Google Patents
